Last Price$15.5(1.1%)
Market Cap$3,104.9M
$2,703.6M
+48.3% YoY
($128.0M)
-13.6% YoY
($425.0M)
Net Debt to FCF - 63.9x
($6,648.0K)
(0.2% margin)
ALHC Income Statement
ALHC Income Statement Overview
Annual
Quarterly
LTM
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
ALHC Income statement key metrics
Annual
Quarterly
LTM
ALHC Balance Sheet
ALHC Balance Sheet Overview
Annual
Quarterly
LTM
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$591.9M
Current assets ($483.5M, 81.7% of total)
$318.8M (53.9%)
$119.7M (20.2%)
Other current assets
$45.0M (7.6%)
Non-current assets ($108.3M, 18.3% of total)
$0.0 (0.0%)
$61.9M (10.5%)
$5,252.0K (0.9%)
Other non-current assets
$41.2M (7.0%)
Financial position
($148.0M)
Cash & Short-term
Investments
Total Debt
ALHC Balance Sheet Metrics
Annual
Quarterly
LTM
ALHC Cash Flow Statement
ALHC Cash Flow Statement Overview
Annual
Quarterly
LTM
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
($206.3M) Net Change in Cash
ALHC Cash Flow Statement key metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
($59.2M) +30.3% YoY
Capital Expenditure (CAPEX)
($36.0M) +51.4% YoY
Free Cash Flow (FCF)
($95.2M) +37.5% YoY
ALHC Financials
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|
% growth | 757.0 0.0% | 959.2 26.7% | 1,167.8 21.7% | 1,434.2 22.8% | 1,823.6 27.2% |
| Cost of Goods Sold (COGS) | 661.4 | 793.0 | 1,039.0 | 1,249.9 | 1,622.6 |
% margin | 95.6 12.6% | 166.2 17.3% | 128.7 11.0% | 184.3 12.8% | 201.0 11.0% |
| Operating Expenses | 125.1 | 171.5 | 306.8 | 312.9 | 328.8 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 110.1 | 156.4 | 291.0 | 295.6 | 307.4 |
% margin | (29.5) (3.9%) | (6.0) (0.6%) | (178.1) (15.2%) | (128.6) (9.0%) | (127.8) (7.0%) |
| Interest Income | 14.9 | 16.9 | 17.4 | 18.3 | 0.0 |
| Interest Expense | 14.9 | 16.9 | 17.4 | 18.3 | 21.2 |
| Pre-tax Income | (44.7) | (22.9) | (195.3) | (149.3) | (148.2) |
% effective tax rate | 14.5 (32.5%) | 16.2 (70.7%) | 17.7 (9.0%) | 0.3 (0.2%) | (0.0) 0.0% |
% margin | (59.3) (7.8%) | (39.1) (4.1%) | (213.0) (18.2%) | (149.6) (10.4%) | (148.0) (8.1%) |
| EPS | (0.32) | (0.21) | (1.24) | (0.83) | (0.79) |
| Diluted EPS | (0.32) | (0.21) | (1.24) | (0.83) | (0.79) |
% margin | (13.3) (1.8%) | 9.5 1.0% | (161.8) (13.9%) | (113.5) (7.9%) | (105.3) (5.8%) |
FAQ
What is the Alignment Healthcare, Inc. (ALHC) revenue?
The Alignment Healthcare, Inc. (ALHC) revenue is $1,823.6M, reflecting a year-over-year (YoY) growth of +27.2% YoY.
What is the Alignment Healthcare, Inc. (ALHC) Net Income?
The Alignment Healthcare, Inc. (ALHC) Net Income is ($148.0M), showcasing a YoY growth of -1.1% YoY.
What is Alignment Healthcare, Inc. (ALHC) net debt?
What is the Alignment Healthcare, Inc. (ALHC) Free Cash Flow (FCF)?
The Alignment Healthcare, Inc. (ALHC) Free Cash Flow (FCF) stands at ($95.2M), accounting for a (5.2%) margin.